New Healthcare Market
Objectives
.Understand the actual situation of the health sector in global terms and in the specific case of Portugal;
.Analyses potential evolution path of the health sector in global terms and in the specific case of Portugal;
.Discuss the workings, advantages and disadvantages of the health systems organizations models;
.Knows the modalities and limits of the health sector public financing and its links with the private sector;
.Identifyn innovations tools in health sector key areas and its potencial impact;
.Discuss the advantages and disadvantages of Public Private Partnership in the health sector;
.Show independence in searching and producing summaries of information on the cconcepts discussed during the course;
General characterization
Code
400024
Credits
4.0
Responsible teacher
Manuel Ferreira Teixeira
Hours
Weekly - Available soon
Total - Available soon
Teaching language
Portuguese. If there are Erasmus students, classes will be taught in English
Prerequisites
None.
Bibliography
- Figueras,J. and Robinson, Ray,, Health System Performance, Open Unersity Press, 2006;
- Preker, A.and Harding, A., eds, Innovations in Health Services, World Bank, 2005;
- World Health Organization, Health System Financing, 2009;
- Sorenson, Corinna and Kanavos, Panos, The Role of Health Technology Assessment, European Observatory, 2008;
Teaching method
The pedagogical methodology is centered in case study process and in the interaction with the experience of the participants.
Evaluation method
The course evaluation has two tracks: 1) quality of the participation (40%); 2) exam (60%).
Subject matter
.Health concept;
.Particularities of the health market;
.The new market of health;
Organizations models;
.Evolution of the health sector;
.National Health Services in the context of the new health market;
.Public and private relationship in the health systems;
.Health financing models;
.Contratual financing models based in production;
.Contratual financing models based in population;
.Risk based financing models;
.Critical factors in the dynamic of the health financing;
.Innovation in the health sector (clinical and technological);
.Pharmaceutical market and innovation;
.Medical devises market and innovation;
.Public Private Partnership (PPP) in the health sector;
.Modalities, experiences and critical factors in health PPP;